Evaluation of Long-term Safety and Performance of PanOptix Intraocular Lens (IOLs)

NACompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

April 27, 2024

Primary Completion Date

February 5, 2025

Study Completion Date

February 5, 2025

Conditions
AphakiaAstigmatismPresbyopia
Interventions
DEVICE

AcrySof IQ PanOptix IOL

Trifocal IOL implanted in the capsular bag in the eye for the visual correction of aphakia in adult patients with less than 1.00 diopter of preoperative corneal astigmatism, with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence.

DEVICE

AcrySof IQ PanOptix Toric IOL

Toric trifocal IOL implanted in the capsular bag in the eye for the visual correction of aphakia and pre-existing corneal astigmatism in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence.

Trial Locations (7)

8022

Institut Catala de la Retina - Sarria, Barcelona

8205

Hospital Universitari General de Catalunya, Sabadell

11408

Oftalvist Jerez - HLA Puerta del Sur, Jerez de la Frontera

14012

Hospital Arruzafa, Córdoba

28033

Miranza IOA, Madrid

28046

Clinicas Novovision - Clinica Madrid, Madrid

08021

Barraquer Ophthalmology Center, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY